It makes sense to trade future profit streams for money today. AHZ needs the cash and if Adapt finally takes off in the future infusion will just be a side show/distraction. They should have flogged it ages ago when a better deal would probably have been had - the real question is how profitable is it really? According to previous helpful posters some periods it makes money, but others a loss. multiplying the profit by 10 would give an indicator of sale price. However they don't split anything out in the annual report so I can't get a clear view on it.
Truth is it might not be worth much if it is not making much.
Ann: Admedus Secures Strategic Investor, page-347
-
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.31 |
Change
0.000(0.00%) |
Mkt cap ! $351.9M | |||
| Open | High | Low | Value | Volume |
| $18.30 | $19.00 | $18.00 | $363.4K | 19.82K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 500 | $18.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.50 | 1000 | 1 |
View Market Depth
| Last trade - 15.59pm 01/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |